By Professor Sean Emery

Journal articles

Harrod ME; Emery S; Dwyer DE, 2006, 'Antivirals in the management of an influenza pandemic', Medical Journal of Australia, 185, pp. S58 - S61

El-Sadr W; Lundgren JD; Neaton JD; Gordin F; Abrams D; Arduino R; Babiker AG; Burman W; Clumeck N; Cohen C; Cohn D; Cooper DA; Darbyshire JH; Emery S; Fatkenheuer G; Gazzard B; Hoy JF; Klingman K; Losso MH; Markowitz N; Neuhaus J; Phillips A; Rappaport C, 2006, 'CD4+ count-guided interruption of antiretroviral treatment.', New England Journal of Medicine, 355, pp. 2283 - 2296

Samaras K; Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2006, 'Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition and metabolic parameters', Antiviral Therapy, 11, pp. L23 - L24

De Rose R; Sullivan MT; Dale CJ; Kelleher AD; Emery S; Cooper DA; Ramshaw I; Boyle D; Kent SJ, 2006, 'Dose-response relationship of DNA and recombinant fowlpox virus prime-boost HIV vaccines.', Human Vaccines, 2, pp. 134 - 136

Assiongbon KA; Emery SB; Gorantla VRK; Babu SV; Roy D, 2006, 'Electrochemical impedance characteristics of Ta/Cu contact regions in polishing slurries used for chemical mechanical planarization of Ta and Cu: considerations of galvanic corrosion', CORROSION SCIENCE, 48, pp. 372 - 388, http://dx.doi.org/10.1016/j.corsci.2005.01.008

Dwyer D; Workman C; Hales GP; Amin J; Cooper DA; Miller J; Emery S, 2006, 'Enfuvirtide in HIV-1-infected individuals changing therapy to a nucleoside reverse transcriptase inhibitor sparing regimen: The ALLIANCE Study', Antiviral Therapy, 11, pp. 409 - 419

Emery S; Dwyer DE; McKinnon M, 2006, 'Epilogue: Preparing for an influenza pandernic in Australia', Medical Journal of Australia, 185, pp. S80 - S80

Winston A; Amin J; Marriott D; Mallon PW; Carr AD; Cooper DA; Emery S, 2006, 'Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy', HIV Medicine, 7, pp. 105 - 111

Winston A; Amin J; Hales GP; Cooper DA; Emery S, 2006, 'Nonnucleoside reverse transcriptase inhibitor fold change or plasma concentration as a predictor of virological response over 48 weeks in highly treatment experienced HIV-positive individuals', AIDS Research and Human Retroviruses, 22, pp. 338 - 341

Pace C; Grady C; Wendler D; Bebchuk JD; Tavel JA; McNay LA; Forster HP; Killen J; Emanuel EJ, 2006, 'Post-trial Access to Tested Interventions: The Views of IRB/REC Chair, Investigators, and Research Participants in a Multinational HIV/AIDS Study', AIDS Research and Human Retroviruses, 22, pp. 837 - 841, http://dx.doi.org/10.1089/aid.2006.22.837

Mocroft A; Neaton JD; Bebchuk JD; Staszewski S; Antunes F; Knysz B; Law MG; Phillips AN; Lundgren JD, 2006, 'The feasibility of clinical endpoint trials in HIV infection in the highly active antiretroviral treatment (HAART) era', CLINICAL TRIALS, 3, pp. 119 - 132

Puls R; Emery S, 2006, 'Therapeutic vaccination against HIV: current progress and future possibilities', Clinical Science, 110, pp. 59 - 71

Yeni PG; Cooper DA; Aboulker J; Babiker AG; Carey DL; Darbyshire JH; Floridia M; Girard P; Goodall R; Hooker M; Mijch AM; Meiffredy V; Salzberger B, 2006, 'Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial.', Lancet, 368, pp. 287 - 298

Emery SB; Hubbley JL; Roy D, 2005, 'Time resolved impedance spectroscopy as a probe of electrochemical kinetics: The ferro/ferricyanide redox reaction in the presence of anion adsorption on thin film gold', ELECTROCHIMICA ACTA, 50, pp. 5659 - 5672, http://dx.doi.org/10.1016/j.electacta.2005.03.043

Emery SB; Hubbley JL; Darling MA; Roy D, 2005, 'Chemical factors for chemical-mechanical and electrochemical-mechanical planarization of silver examined using potentiodynamic and impedance measurements', MATERIALS CHEMISTRY AND PHYSICS, 89, pp. 345 - 353, http://dx.doi.org/10.1016/j.matchemphys.2004.09.011

Mallon PWG; Wand H; Law M; Miller J; Cooper DA; Carr A, 2005, 'Buffalo hump seen in HIV-associated lipodystrophy is associated with hyperinsulinemia but not dyslipidemia', Journal of Acquired Immune Deficiency Syndromes, 38, pp. 156 - 162, http://dx.doi.org/10.1097/01.qai.0000147527.64863.1a

Duncombe C; Kerr SJ; Ruxrungtham K; Dore GJ; Law MG; Emery S; Lange JM; Phanuphak P; Cooper DA, 2005, 'HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting', AIDS, 19, pp. 169 - 178, http://dx.doi.org/10.1097/00002030-200501280-00009

Sabik L; Pace CA; Forster-Gertner HP; Wendler D; Bebchuk JD; Tavel JA; McNay LA; Killen J; Emanuel EJ; Grady C, 2005, 'Informed consent: Practices and views of investigators in a multinational clinical trial', IRB Ethics and Human Research, 27, pp. 13 - 18, http://dx.doi.org/10.2307/3564530

Emery S; Workman C; Puls RL; Bloch M; Baker D; Bodsworth N; Anderson J; Crowe SM; French MA; Hoy J; Aichelburg A; Ward LD; Boyle DB; Law MG; Kelleher AD; Cooper DA, 2005, 'Randomized, placebo-controlled, phase I/IIa evaluation of the safety and immunogenicity of fowlpox virus expressing HIV gag-pol and interferon-gamma in HIV-1 infected subjects.', Human Vaccines, 1, pp. 232 - 238, http://dx.doi.org/10.4161/hv.1.6.2342

Pace C; Emanuel EJ; Chuenyam T; Duncombe C; Bebchuk JD; Wendler D; Tavel JA; McNay LA; Phanuphak P; Forster HP; Grady C, 2005, 'The quality of informed consent in a clinical research study in Thailand', IRB Ethics and Human Research, 27, pp. 9 - 17, http://dx.doi.org/10.2307/3563866

Winston A; Bloch MT; Carr AD; Amin J; Mallon PW; Ray J; Marriott D; Cooper DA; Emery S, 2005, 'Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy', Journal of Antimicrobial Chemotherapy, 56, pp. 380 - 387

Gorantla VRK; Emery SB; Pandija S; Babu SV; Roy D, 2005, 'Chemical effects in chemical mechanical planarization of TaN: investigation of surface reactions in a peroxide-based alkaline slurry using Fourier transform impedance spectroscopy', Materials Letters, 59, pp. 690 - 693, http://dx.doi.org/10.1016/j.matlet.2004.11.010

Winters B; Harrigan R; Montaner JS; Perez-Elias M; Miller M; Emery S; van Leth F; Robinson P; Baxter J; Gazzard B; Pozniak A; Castor D; Hammer S; Rinehart A; Bacheler L, 2005, 'Clinically relevant breakpoints for virco (R) TYPE HIV-1 phenotypic resistance information', Antiviral Therapy, 10, pp. S39 - S39

Carey DL; Wand HC; Martin A; Rothwell S; Emery S; Cooper DA; Carr AD, 2005, 'Evaluation of ultrasound for assessing facial lipoatrophy in a randomized, placebo-controlled trial', AIDS, 19, pp. 1325 - 1327

Mallon PW; Unemori P; Sedwell R; Morey AL; Rafferty M; Williams KM; Chisholm DJ; Samaras K; Emery S; Kelleher AD; Cooper DA; Carr AD, 2005, 'In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA', Journal of Infectious Diseases, 191, pp. 1686 - 1696

Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2005, 'Increase in limb fat after nucleoside analogue cessation is not associated with decreased visceral fat and has different risk factors', Antiviral Therapy, 10, pp. L5 - L5

Kovacic JC; Martin A; Carey DL; Wand HC; Mallon PW; Feneley MP; Emery S; Cooper DA; Carr AD, 2005, 'Influence of rosiglitazone on flow-mediated dilation and other markers of cardiovascular risk in HIV-infected patients with lipoatrophy', Antiviral Therapy, 10, pp. 135 - 143

Winston A; Hales GP; Amin J; van Schaick E; Cooper DA; Emery S, 2005, 'The normalized inhibitory quotient of boosted protease inhibitors is predictive of viral load response in treatment-experienced HIV-1-infected individuals', AIDS, 19, pp. 1393 - 1399

Dale CJ; De Rose R; Wilson KM; Croom HA; Thomson S; Coupar BEH; Ramsay A; Purcell DFJ; Ffrench R; Law M; Emery S; Cooper DA; Ramshaw IA; Boyle DB; Kent SJ, 2004, 'Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFNγ or IL-12', Vaccine, 23, pp. 188 - 197, http://dx.doi.org/10.1016/j.vaccine.2004.05.024

Emery SB; Hubbley JL; Roy D, 2004, 'Voltammetric and amperometric analyses of electrochemical nucleation: electrodeposition of copper on nickel and tantalum', JOURNAL OF ELECTROANALYTICAL CHEMISTRY, 568, pp. 121 - 133, http://dx.doi.org/10.1016/j.jelechem.2004.01.012

Carr A; Workman C; Carey D; Rogers G; Martin A; Baker D; Wand H; Law M; Samaras K; Emery S; Cooper DA, 2004, 'No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: Randomised, double-blind, placebo-controlled trial', Lancet, 363, pp. 429 - 438, http://dx.doi.org/10.1016/S0140-6736(04)15489-5

Pett SL; Williams LA; Day RO; Lloyd AR; Carr AD; Clezy KR; Emery S; Kaplan E; Mcphee D; Mclachlan AJ; Gelder F; Lewin S; Liauw WS; Williams KM, 2004, 'A phase I study of the pharmacokinetics and safety of passive immunotherapy with caprine anti-HIV antibodies, (PE)HRG214, in HIV-1-infected individuals', HIV Clinical Trials, 5, pp. 91 - 98

Arduino R; Nannini E; Rodriguez-Barradas M; Schrader S; Losso MH; Ruxrungtham K; Allende MC; Emery S; Fosdick L; Neaton JD; Tavel JA; Davey R; Lane HC, 2004, 'CD4 cell response to 3 doses of subcutaneous interleukin 2:Meta-analysis of 3 Vanguard studies', Clinical Infectious Diseases, 39, pp. 115 - 122

Mallon PW; Sedwell R; Unemori P; Rafferty M; Williams KM; Chisholm DJ; Samaras K; Emery S; Kelleher AD; Cooper DA; Carr AD, 2004, 'Changes in nuclear gene expression resulting from NRTI-induced inhibition of mitochondrial transcription reveal links between mitochondrial dysfunction and lipid metabolism', Antiviral Therapy, 9, pp. L56 - L56

Assiongbon KA; Emery SB; Pettit CM; Babu SV; Roy D, 2004, 'Chemical roles of peroxide-based alkaline slurries in chemical–mechanical polishing of Ta: investigation of surface reactions using time-resolved impedance spectroscopy', Materials Chemistry and Physics, 86, pp. 347 - 357, http://dx.doi.org/10.1016/j.matchemphys.2004.03.016

Mallon PW; Unemori P; Sedwell R; Morey AL; Rafferty M; Williams KM; Chisholm DJ; Samaras K; Emery S; Kelleher AD; Cooper DA; Carr AD, 2004, 'In vivo nucleoside reverse transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes independent to HIV infection', Antiviral Therapy, 9, pp. L11 - L11

McClelland RS; Baeten JM; Overbaugh J; Richardson BA; Mandaliya K; Emery S; Lavreys L; Ndinya-Achola JO; Bankson DD; Bwayo JJ; Kreiss JK, 2004, 'Micronutrient Supplementation Increases Genital Tract Shedding of HIV-1 in Women', JAIDS Journal of Acquired Immune Deficiency Syndromes, 37, pp. 1657 - 1663, http://dx.doi.org/10.1097/00126334-200412150-00021

Martin A; Smith DE; Carr AD; Ringland C; Amin J; Emery S; Hoy JF; Workman C; Doong N; Freund J; Cooper DA, 2004, 'Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study', AIDS, 18, pp. 1029 - 1036, http://www.medscape.com/viewarticle/474870

Carey DL; Workman C; Rogers GJ; Baker DA; Martin A; Wand HC; Emery S; Cooper DA; Carr AD, 2004, 'Rosiglitazone for HIV lipoatrophy: 84 weeks follow-up', Antiviral Therapy, 9, pp. L46 - L46

Ungsedhapand C; Srasuebkul P; Cardiello P; Ruxrungtham K; Ratanasuwan W; Kroon E; Tongtalung M; Juengprasert N; Ubolyam S; Siangphoe U; Emery S; Lange JM; Cooper DA; Phanuphak P, 2004, 'Three-year durability of dual-nucleoside versus triple-nucleoside therapy in a Thai population with HIV infection', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 36, pp. 693 - 701

Sirivichayakul S; Ruxrungtham K; Ungsedhapand C; Techasathit W; Ubolyam S; Chuenyam T; Emery S; Cooper D; Lange J; Phanuphak P, 2003, 'Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitors', AIDS, 17, pp. 1889 - 1896, http://dx.doi.org/10.1097/00002030-200309050-00007

Carr A; Law M, 2003, 'An objective lipodystrophy severity grading scale derived from the lipodystrophy case definition score', Journal of Acquired Immune Deficiency Syndromes, 33, pp. 571 - 576, http://dx.doi.org/10.1097/00126334-200308150-00004

Amin J; Moore A; Carr A; French MA; Law M; Emery S; Cooper DA, 2003, 'Combined Analysis of Two-Year Follow-Up from Two Open-Label Randomized Trials Comparing Efficacy of Three Nucleoside Reverse Transcriptase Inhibitor Backbones for Previously Untreated HIV-1 Infection: OzCombo 1 and 2', HIV Research & Clinical Practice, 4, pp. 252 - 261, http://dx.doi.org/10.1310/hct.2003.4.4.004

Amin J; Moore A; Carr A; French MA; Law M; Emery S; Cooper DA; Kotsiou G; Norrito L; Dwyer D; Packham D; Fordham M; Garsia R; Baker D; Doong N; Quan D; Beveridge A; Genn W; Quin J; Mulholland J; Sowden D; Rawlinsen M; Rebic D; Street A; De Graaf B; Roney J; Bryant M; McCormack C; Hoy J; Shaw D; Ferguson W; Waddell R; Papanaoum K; French M; Mallal S; Scull N; Todhunter L; Jacobs S; James R; Foreman E; Chuah J; Watson A; Bowden F; Little B; Willington C; Habel P; Mills G; Morgan J; Thomas M; Porteous F; Franklin R; Reid M; Munro R; Sharkey T; Hudson J; Groves J; Blunt J; Clezy K; Lee W; Smith D; Cunningham P; Wood H, 2003, 'Combined analysis of two-year follow-up from two open-label randomized trials comparing efficacy of three nucleoside reverse transcriptase inhibitor backbones for previously untreated HIV-1 infection: Ozcombo 1 and 2', HIV Clinical Trials, 4, pp. 252 - 261, http://dx.doi.org/10.1310/K2U9-QC2V-1Y3V-5DYF

Miller J; Carr A; Emery S; Law M; Mallal S; Baker D; Smith D; Kaldor J; Cooper DA, 2003, 'HIV lipodystrophy: Prevalence, severity and correlates of risk in Australia', HIV Medicine, 4, pp. 293 - 301, http://dx.doi.org/10.1046/j.1468-1293.2003.00159.x

Carr A; Emery S; Law M; Puls R; Lundgren JD; Powderly WG; Barr D; Cooper DA; Grinspoon S; Ioannidis J; Lewis R; Lichtenstein K; Murray J; Pizzuti D; Rozenbaum W; Schambelan M; Moore A; Miller J, 2003, 'An objective case definition of lipodystrophy in HIV-infected adults: A case-control study', Lancet, 361, pp. 726 - 735, http://dx.doi.org/10.1016/S0140-6736(03)12656-6

Law MG; Emery S, 2003, 'Selective exclusion of treatment arms in multi-arm randomized clinical trials', Statistics in Medicine, 22, pp. 19 - 30, http://dx.doi.org/10.1002/sim.1308

Sayer DC; Land S; Gizzarelli L; French M; Hales G; Emery S; Christiansen FT; Dax EM; Dunne M; Crowe S; Birch C; Middleton T; Saksena N; Bryson G; Salem H; Cunningham P; Suzuki K; Schroeder B; Rawlings L; Higgins G; Chuah J; Roth N; Barnes T; Mills G; Daye J; Watson J, 2003, 'Quality assessment program for genotypic antiretroviral testing improves detection of drug resistance mutations', Journal of Clinical Microbiology, 41, pp. 227 - 236, http://dx.doi.org/10.1128/JCM.41.1.227-236.2003

Berdyyeva TK; Emery SB; Sokolov IY, 2003, 'In situ AFM study of surface layer removal during copper CMP', ELECTROCHEMICAL AND SOLID STATE LETTERS, 6, pp. G91 - G94, http://dx.doi.org/10.1149/1.1576051

Clegg AO; Williamson P; Biti RA; Cooper DA; Emery S; Carr AD; Stewart GJ, 2003, 'Chemokine receptor genotype and response to interleukin-2 therapy in HIB-1-infected individuals', Clinical Immunology, 106, pp. 36 - 40

Back to profile page